
Annual report 2022
added 09-30-2022
Dogness (International) Corporation Financial Ratios 2011-2026 | DOGZ
Annual Financial Ratios Dogness (International) Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
10.4 | 36.4 | -3.1 | 52.5 | 13.9 | 12.1 | - | - | - | - | - | - |
P/S |
1.2 | 2.3 | 1.4 | 2.8 | 2.1 | 2.8 | - | - | - | - | - | - |
EPS |
0.1 | 0.1 | -0.3 | 0.1 | 0.2 | 0.3 | 0.2 | - | - | - | - | - |
EV (Enterprise Value) |
29.4 M | 79 M | 36.7 M | 80.2 M | 65.8 M | 70.2 M | 8.17 M | - | - | - | - | - |
EBITDA per Share |
0.1 | 0.18 | -0.25 | 0.0813 | 0.344 | 0.44 | - | - | - | - | - | - |
EV/EBITDA |
15.9 | -6.4 | 35.6 | 8.6 | - | - | - | - | - | - | - | |
PEG |
- | 0.01 | -0.7 | 0.84 | - | - | - | - | - | - | - | |
P/B |
0.4 | 0.8 | 0.5 | 1.2 | 1.1 | 8.2 | - | - | - | - | - | - |
P/CF |
5.5 | 14.7 | -11.7 | -4.1 | -5.3 | 10.9 | - | - | - | - | - | - |
ROE % |
3.67 | 2.35 | -16.39 | 2.33 | 7.58 | 67.22 | - | - | - | - | - | - |
ROA % |
3.21 | 1.61 | -13.28 | 2.06 | 6.62 | 28.23 | - | - | - | - | - | - |
ROCE % |
0.08 | 2.58 | -16.51 | 1.05 | 9.78 | 78.96 | - | - | - | - | - | - |
Current Ratio |
8.2 | 3.2 | 5.3 | 3.2 | 5.2 | 1.7 | - | - | - | - | - | - |
DSO |
37.9 | 40.2 | 72.7 | 75.3 | 68.3 | - | - | - | - | - | - | - |
DIO |
81.5 | 85.0 | 89.4 | 116.6 | 84.2 | - | - | - | - | - | - | - |
DPO |
20.2 | 18.7 | 13.6 | 11.8 | 7.1 | - | - | - | - | - | - | - |
Operating Cycle |
119.4 | 125.2 | 162.2 | 191.9 | 152.6 | - | - | - | - | - | - | - |
Cash Conversion Cycle |
99.2 | 106.5 | 148.6 | 180.1 | 145.4 | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Dogness (International) Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
- | - | - | - | 4.0 | - | 3.2 | - | 4.1 | - | 5.3 | - | - | - | 8.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Dogness (International) Corporation, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Financial Ratios of other stocks in the Household products industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
Natura &Co Holding S.A.
NTCO
|
- | - | $ 9.02 B | - | |
|
Colgate-Palmolive Company
CL
|
$ 84.16 | 0.21 % | $ 68.1 B | ||
|
The Clorox Company
CLX
|
$ 104.44 | 1.02 % | $ 12.9 B | ||
|
Helen of Troy Limited
HELE
|
$ 17.34 | 2.79 % | $ 399 M | ||
|
Church & Dwight Co.
CHD
|
$ 95.53 | 0.53 % | $ 23.2 B | ||
|
Kimberly-Clark Corporation
KMB
|
$ 97.16 | 0.58 % | $ 32.2 B | ||
|
e.l.f. Beauty
ELF
|
$ 68.9 | 5.0 % | $ 3.77 B | ||
|
Inter Parfums
IPAR
|
$ 96.12 | 0.66 % | $ 3.09 B | ||
|
LifeVantage Corporation
LFVN
|
$ 4.14 | -0.84 % | $ 50.7 M | ||
|
Coty
COTY
|
$ 2.28 | 0.88 % | $ 1.99 B | ||
|
Mannatech, Incorporated
MTEX
|
$ 4.84 | -3.2 % | $ 9.03 M | ||
|
The Estée Lauder Companies
EL
|
$ 76.42 | 2.51 % | $ 27.5 B | ||
|
Nature's Sunshine Products
NATR
|
$ 26.81 | 0.22 % | $ 483 M | ||
|
Nu Skin Enterprises
NUS
|
$ 7.74 | 3.06 % | $ 382 M | ||
|
Hims & Hers Health
HIMS
|
$ 21.36 | 0.99 % | $ 4.81 B | ||
|
Edgewell Personal Care Company
EPC
|
$ 22.44 | 1.08 % | $ 1.12 B | ||
|
Newell Brands
NWL
|
$ 4.04 | 4.66 % | $ 1.69 B | ||
|
Unilever PLC
UL
|
$ 57.81 | -0.72 % | $ 132 B | ||
|
United-Guardian
UG
|
$ 6.54 | -0.76 % | $ 30 M | ||
|
Acme United Corporation
ACU
|
$ 45.22 | -1.67 % | $ 171 M | ||
|
The Procter & Gamble Company
PG
|
$ 144.38 | 0.56 % | $ 339 B | ||
|
Spectrum Brands Holdings
SPB
|
$ 80.25 | 1.7 % | $ 2.06 B | ||
|
Revlon
REV
|
- | -4.41 % | $ 212 M | ||
|
USANA Health Sciences
USNA
|
$ 18.51 | 1.87 % | $ 343 M |